Target intelligence / Profile preview

Signal-induced proliferation-associated 1-like protein 3 (SIPA1L3)

Target
SIPA1L3
Molecular classification
Enzyme, GTPase-activating protein (GAP), Other (contains RapGAP and PDZ domains, and a leucine zipper and coiled-coil domain)
01

Overview

Signal-induced proliferation-associated 1-like protein 3 (SIPA1L3) is a member of the signal induced proliferation associated 1 family, encoding a GTPase-activating protein (GAP) specific for the small GTPase Rap1, and is characterized by the presence of RapGAP and PDZ domains, as well as a C-terminal coiled-coil and a leucine zipper domain[3][4][5]. The protein plays a critical role in epithelial cell morphogenesis, polarity, adhesion, and cytoskeletal organization, especially in the lens of the eye[3][5]. Loss-of-function mutations or dysregulation of SIPA1L3 disrupt these processes and have been linked to congenital cataracts and other eye development abnormalities in humans and animal models[3][4][5]. SIPA1L3 modulates Rap signaling—a key regulator of cell junctions, cytoskeletal dynamics, and tissue morphogenesis[4][5]. In addition, epigenetic changes at SIPA1L3 associate with lung adenocarcinoma prognosis[5]. While it shares homology and functional domains with other family members such as SIPA1 and SIPA1L1, most evidence points to its specialized role in lens and epithelial biology, with possible additional roles in cancer biology through modulation of signaling and cell structure[5][4]. No drugs are currently known to target SIPA1L3, nor is it established as a therapeutic target, but it may serve as a biomarker in certain contexts such as DNA methylation in cancer[5][3][4].

Other names
SPAL3KIAA0545SPAR3SIPA1-like protein 3SPA-1-like protein 3spine-associated RapGAP 3CTRCT45
02

Biological functions

Epithelial cell morphogenesisCell polarityCell adhesionCytoskeletal organizationSignal transductionOther (specifically in the lens)
03

Disease associations

Congenital cataractLens morphogenesis disordersPotential modifier in lung adenocarcinomaOther (ocular anterior segment abnormalities)
04

Biomarkers

DNA methylation site cg02268510 of SIPA1L3 (for survival benefit from smoking cessation in lung adenocarcinoma)[5]

Beyond the preview

Go deeper on Signal-induced proliferation-associated 1-like protein 3 (SIPA1L3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal-induced proliferation-associated 1-like protein 3 (SIPA1L3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call